Scarica l'app Stockscreener
1.41
4.73%
-0.07
Dopo l'orario di chiusura:
1.47
0.06
+4.26%
Precedente Chiudi:
$1.48
Aprire:
$1.48
Volume 24 ore:
125.25K
Relative Volume:
0.55
Capitalizzazione di mercato:
$6.45M
Reddito:
$895.50K
Utile/perdita netta:
$-26.30M
Rapporto P/E:
-0.8598
EPS:
-1.64
Flusso di cassa netto:
$-23.84M
1 W Prestazione:
-7.24%
1M Prestazione:
-12.96%
6M Prestazione:
-55.94%
1 anno Prestazione:
-88.92%
Intervallo 1D:
$1.40
$1.5044
Intervallo di 1 settimana:
$1.40
$1.65
Portata 52W:
$1.2801
$14.39
Mainz Biomed N V Stock (MYNZ) Company Profile
Nome
Mainz Biomed N V
Settore
Industria
Telefono
-
Indirizzo
-
Confronta MYNZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.41 | 8.34M | 895.50K | -26.30M | -23.84M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | Maxim Group | Buy |
| 2024-11-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Iniziato | H.C. Wainwright | Buy |
Mainz Biomed N V Borsa (MYNZ) Ultime notizie
Can Mainz Biomed N.V. stock continue upward trendJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Is it too late to sell Mainz Biomed N.V.Trade Exit Summary & Detailed Earnings Play Alerts - newser.com
Will Mainz Biomed N.V. stock remain a Wall Street favoritePortfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
Mainz Biomed to Attend 2025 Maxim Growth Summit - GlobeNewswire
Oct 22-23, 2025 — Mainz Biomed at Maxim Growth Summit in NYC; one-on-one meetings with investors - Stock Titan
Technical analysis overview for Mainz Biomed N.V. stock2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Analyzing drawdowns of Mainz Biomed N.V. with statistical toolsLayoff News & Reliable Breakout Forecasts - newser.com
Risk vs reward if holding onto Mainz Biomed N.V.Insider Buying & Free Technical Pattern Based Buy Signals - newser.com
Relative strength of Mainz Biomed N.V. in sector analysisMarket Risk Summary & Fast Moving Market Watchlists - newser.com
How Mainz Biomed N.V. (4TO) stock expands through international marketsJuly 2025 Macro Moves & AI Enhanced Trading Signals - newser.com
How Mainz Biomed N.V. (4TO) stock reacts to monetary easingOptions Play & Advanced Swing Trade Entry Plans - newser.com
Blood test detects pancreatic cancer early - European Biotechnology Magazine
Developing predictive dashboards with Mainz Biomed N.V. dataJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
Will Mainz Biomed N.V. (4TO) stock benefit from mergersJuly 2025 Reactions & Long-Term Growth Plans - newser.com
What drives Mainz Biomed NV stock priceMarket Entry Points & Free Stock Predictions and Analysis - earlytimes.in
Mainz Biomed (NASDAQ:MYNZ) Trading Down 3% – Here’s What Happened - Defense World
Mainz Biomed (NASDAQ:MYNZ) Trading Down 3% – What’s Next? - Defense World
How forex fluctuations impact Mainz Biomed N.V. (4TO) stock2025 Market Sentiment & Breakout Confirmation Alerts - newser.com
Mainz Biomed reports promising results for pancreatic cancer blood test By Investing.com - Investing.com Nigeria
Mainz Biomed reports promising results for pancreatic cancer blood test - Investing.com
Mainz Biomed N.V. Reports Positive Results from Feasibility Study for Non-Invasive Pancreatic Cancer Screening Test - Quiver Quantitative
100% sensitivity: Mainz Biomed biomarker panel shows 95% specificity in 30‑patient pancreatic study - Stock Titan
What analysts say about Mainz Biomed NV stockMarket Correction Analysis & Outstanding Profit Strategies - earlytimes.in
Can Mainz Biomed N.V. recover in the next quarter2025 Analyst Calls & Verified Entry Point Detection - newser.com
Visual analytics tools that track Mainz Biomed N.V. performanceInsider Selling & AI Forecasted Stock Moves - newser.com
What MACD and RSI say about Mainz Biomed N.V.CPI Data & High Return Stock Watch Alerts - newser.com
Real time breakdown of Mainz Biomed N.V. stock performance2025 Price Targets & Fast Entry High Yield Stock Tips - newser.com
Real time pattern detection on Mainz Biomed N.V. stockSell Signal & Daily Growth Stock Tips - newser.com
Can swing trading help recover from Mainz Biomed N.V. lossesJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting - GlobeNewswire
Mainz Biomed to Present Innovative RNA-based Colorectal Cancer Screening Findings at World Endoscopy Organization Meeting - Quiver Quantitative
Mainz Biomed N V Azioni (MYNZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):